Check out the study “Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity”

CRS’s Expertise
Share

Have you already read the latest publication on PubMed ?

Check out the study “Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies” to delve into the key findings and implications. We congratulate the team for their hard work and dedication! Read the publication here: https://pubmed.ncbi.nlm.nih.gov/36958671/